Frontiers in Immunology (Nov 2017)

Single Dose of Consensus Hemagglutinin-Based Virus-Like Particles Vaccine Protects Chickens against Divergent H5 Subtype Influenza Viruses

  • Peipei Wu,
  • Peipei Wu,
  • Peipei Wu,
  • Jihu Lu,
  • Jihu Lu,
  • Jihu Lu,
  • Xuehua Zhang,
  • Xuehua Zhang,
  • Xuehua Zhang,
  • Mei Mei,
  • Mei Mei,
  • Mei Mei,
  • Lei Feng,
  • Lei Feng,
  • Lei Feng,
  • Daxin Peng,
  • Daxin Peng,
  • Jibo Hou,
  • Jibo Hou,
  • Jibo Hou,
  • Sang-Moo Kang,
  • Xiufan Liu,
  • Xiufan Liu,
  • Yinghua Tang,
  • Yinghua Tang,
  • Yinghua Tang

DOI
https://doi.org/10.3389/fimmu.2017.01649
Journal volume & issue
Vol. 8

Abstract

Read online

The H5 subtype highly pathogenic avian influenza (HPAI) virus is one of the greatest threats to global poultry industry. To develop broadly protective H5 subunit vaccine, a recombinant consensus HA sequence (rHA) was constructed and expressed in virus-like particles (rHA VLPs) in the baculovirus-insect cell system. The efficacy of the rHA VLPs vaccine with or without immunopotentiator (CVCVA5) was assessed in chickens. Compared to the commercial Re6 or Re6-CVCVA5 vaccines, single dose immunization of chickens with rHA VLPs or rHA-CVCVA5 vaccines induced higher levels of serum hemagglutinin inhibition titers and neutralization titers, mucosal antibodies, IFN-γ and IL-4 cytokines in sera, and cytotoxic T lymphocyte responses. The rHA VLPs vaccine was superior to the commercial Re6 vaccine in conferring cross-protection against different clades of H5 subtype viruses. This study reports that H5 subtype consensus HA VLP single dose vaccination provides broad protection against HPAI virus in chickens.

Keywords